Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

BACKGROUND: Tumor human papillomavirus (HPV) status is an important prognostic factor in locoregionally advanced squamous cell carcinoma of the head and neck (SCCHN). Prognostic value in recurrent and/or metastatic (R/M) disease remains to be confirmed. This retrospective analysis of the EXTREME tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermorken, J. B., Psyrri, A., Mesía, R., Peyrade, F., Beier, F., de Blas, B., Celik, I., Licitra, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969553/
https://www.ncbi.nlm.nih.gov/pubmed/24577117
http://dx.doi.org/10.1093/annonc/mdt574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969553/
https://www.ncbi.nlm.nih.gov/pubmed/24577117
http://dx.doi.org/10.1093/annonc/mdt574

Ejemplares similares